Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Shares Issued: 2023-2024

Historic Shares Issued for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $71.7 million.

  • Inhibrx Biosciences' Shares Issued was N/A to $352,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $270.8 million, marking a year-over-year change of. This contributed to the annual value of $71.7 million for FY2024, which is 64.16% down from last year.
  • Latest data reveals that Inhibrx Biosciences reported Shares Issued of $71.7 million as of FY2024, which was down 64.16% from $200.0 million recorded in FY2023.
  • In the past 5 years, Inhibrx Biosciences' Shares Issued registered a high of $200.0 million during FY2023, and its lowest value of $71.7 million during FY2024.
  • For the 2-year period, Inhibrx Biosciences' Shares Issued averaged around $135.8 million, with its median value being $135.8 million (2023).
  • Data for Inhibrx Biosciences' Shares Issued shows a maximum YoY plummeted of 64.16% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Shares Issued stood at $200.0 million in 2023, then slumped by 64.16% to $71.7 million in 2024.